Nutrigenomics studies the effects of food and its constituents at molecular level so as to gain insight into the mechanisms of interaction between nutrients and other dietary bioactives with the genome. Nutrigenomics aims to understand the body's response to different types of diets and food through various 'omics' techniques including transcriptomics, proteomics and metabolomics, although the most common technique used is transcriptomic analysis (1) . Tools used to measure the transcriptome are well developed including gene expression microarray profiling, single nucleotide polymorphisms (SNPs) and genotyping. In contrast, tools to measure the proteome and metabolome are less developed including techniques such as gel electrophoresis, mass spectophotometry, nuclear magnetic resonance imaging, and chromatography (2); This technique has provided a considerable amount of data on several factors such as novel function of food factors, the unknown mechanism of the effect of nutrients, and even safety issues of foods (3) . Nutrigenomics is emerging as a new competent field in research that integrates genetics and dietary recommendations to study protein expression and metabolite production.
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Nutrigenomics can help improve our understanding of how nutrition influences metabolic pathways and homeostatic control, which can be used to discover naturally occurring chemical agents in food to help prevent the onset of diseases such as obesity, type-2 diabetes and cancer. Nutrigernomics, also involves determining certain genes and markers during the early phase of diet-related diseases. Once such a marker or a gene is identified and measured in an individual, the degree to which they can be susceptible to the onset of that particular disease can be quantified and a personalized dietary recommendation can be established for the individual. Nutrigenomics aims to elucidate the effect of bioactive food compounds on health that can lead to the development of functional foods that keep people healthy according to their individual needs. One area of particular research interest in nutrigenomics can include Complementary Alternative Medicine (CAM). Recently, research in CAM includes identification of the active compounds present in various herbal and dietary products, and evaluating their anti-cancer properties. Polyphenols from green tea, grape seed/skin, anthocyanin and pigments from many flowers, algae, fruits and vegetables are some of the compounds that have been tested. A common property of many of these compounds is their anti-oxidant/free radical scavenging ability. However, some compounds preferentially induce high free radical formation selectively in cance cells, to cause growth inhibition and death of cancer cells without affecting normal cells. Extensive studies on CAM have focused on effects of individual compounds derived from herbs/plants, using concentrations that are typically higher than their 'bioavailable' concentration (the serum levels achieved by oral intake of extracts, as practiced in CAM). However, only few studies explored the effects of these compounds when used in synergistic, additive or antagonistic combinations; and each of the individual chemicals used in a combination could target multiple signaling pathways in the cancer cell. One of the striking features of oral administration of CAM was the low toxicity and showed effects on various types of cancers. The synergistic and / or additive mechanisms that come into play during combination therapies result in reducing the "effective dose" to 'bioavailable' levels. Thus while individual compounds are not effective by themselves, combination becomes effective.
In collaboration with Prof. Madhwa Raj's group (the Louisiana State University, New Orleans, Louisiana), and based on the idea of Synergism theory we performed extensive studies where we tested the effects of the combination of 2 compounds, Indole-3-carbinol (I3C) and Resveratrol, each used at 'bioavailable' levels, on SK-OV-3 ovarian cancer cells (3) . SK-OV-3 cells were treated with various doses of I3C, RE or I3C+RE and proliferation assay was used to examine cell growth. The study revealed that I3C+RE synergized to induce a higher number of cell death than each of these compounds used individually (3). Analysis of apoptosis-associated genes revealed inhibition of Retinoblastoma protein (Rb) and Survivin (SVV) gene expression levels; this was accompanied by elevation of p21, a p53-downstream transcriptional target gene (3). Cell cycle was inhibited at both G1 and G2/M by individual treatments, and accentuated by a combination. ELISA revealed that while, CA125 was inhibited by either I3C or RE treatments, basal nitric oxide production was inhibited by I3C and I3C + RE but not RE alone (3), in addition microarray analysis was performed and we have identified several unique genes that are overexpressed as a result of combination therapy (manuscript in preparation). Ongoing studies in our laboratories are testing the combination of dozens of other compounds in several cancers In addition; selected phytochemical combinations will be tested to validate their anti-cancer effects in vivo using xenograft model of breast cancer (4) . Future work will include the establishment of a powerful combination of compounds (each  I3C induces apoptosis, inhibits cell growth and has antiangiogenic activities  I3C induces G1 cell cycle arrest and inactivates Akt  I3C inhibits activation of transcription factors including nuclear factorkappa B, SP1, estrogen receptor, androgen receptor and nuclear factor-E2-related factor 2 (Nrf2) Grape skin and seeds
Resveratrol (RE)
 RE interferes with AKT, enhances p53, and induces apoptosis  RE exhibits Cox-1 inhibitory activity, and causes G1 arrest 
